Klcm Advisors, Inc. Gilead Sciences, Inc. Transaction History

Klcm Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $2.29 Million - $2.64 Million	36,203 New	36,203 $2.48 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $107,291 - $122,554	1,802 Added 3.97%	47,240 $2.91 Million
Q2 2022 Aug 04, 2022	BUY	$57.72 - $65.01 $2.62 Million - $2.95 Million	45,438 New	45,438 $2.81 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Klcm Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Klcm Advisors, Inc. with notifications on news.